METIRRA
LIVE

Serial Number

79432839

Owner

Envision Sciences Pty Ltd

Attorney

Carrie Hedayati

Filing Date

Jul 9, 2025

Add to watchlist:

No watchlists yet
View on USPTO

METIRRA Trademark

Serial Number: 79432839 • Registration: 8309499

METIRRA is a trademark filed by Envision Sciences Pty Ltd on July 9, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Envision Sciences Pty Ltd (2 trademarks)

Suite 1, Level 3,

Entity Type: 99

Metirra Pty Ltd (2 trademarks)

Suite 1.01

Entity Type: 98

Trademark Details

Filing Date

July 9, 2025

Registration Date

June 23, 2026

Published for Opposition

May 5, 2026

Goods & Services

Pharmaceutical products for the prevention and treatment of cancer; medical preparations for the treatment of cancer; pharmaceutical and veterinary preparations and substances for the treatment of cancerous tumors; medical biological preparations and substances for the prevention and treatment of infectious diseases; diagnostic biomarker reagents for medical purposes; diagnostic biomarkers for in vitro testing for medical use; diagnostic biomarkers for use in assessment of genomic analysis for medical use; diagnostic biomarkers for use in assessment of chemical skin sensitizers for medical use; diagnostic biomarkers for use in assessment of toxicological property of chemical compounds and mixtures for medical use; biopharmaceuticals for the treatment of cancer; biotechnological preparations for medical purposes and medical use, namely, biological reagents for medical purposes; biocides; diagnostic biomarkers for use in assessment of chemical respiratory sensitizers for medical use; diagnostic reagents and assays for detecting antigens for medical purposes; biotherapeutics, namely, therapeutic pharmaceutical for the treatment of cancer; pharmaceutical biosimilars for human use for the treatment of cancer; medical preparations, namely, immunotherapeutic agents for the treatment and prevention of cancers and tumors; diagnostic biomarkers and medical antibodies for use in medical imaging

Disease diagnosis services being performing diagnosis of diseases; medical analysis for the diagnosis and treatment of persons; medical analysis services for the diagnosis and treatment of persons; medical analysis services for cancer diagnosis and prognosis; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical services; medical services, namely, consulting services in the field of healthcare; medical consultancy services; provision of information in the field of cancer prevention, screening, diagnosis, and treatment; RNA or DNA analysis for cancer diagnosis and prognosis; medical pathology services; medical services in the field of oncology; providing medical information to patients and medical professionals in the form of medical reports in the field of cancer prevention, screening, diagnosis, and treatment; medical information; consulting services in the field of medical care

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 23, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 23, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 5, 2026 NPUB
PUBLISHED FOR OPPOSITION
May 5, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 29, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 6, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 1, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 1, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 1, 2026 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 13, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 13, 2026 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 13, 2026 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 13, 2026 COAR
REFUSAL PROCESSED BY IB
Mar 12, 2026 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 26, 2026 RFCS
REFUSAL PROCESSED BY MPU
Feb 26, 2026 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 30, 2026 RFCR
NON-FINAL ACTION WRITTEN
Jan 29, 2026 CNRT
ASSIGNED TO EXAMINER
Jan 29, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 28, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 28, 2026 NWOS
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jan 22, 2026 ADCH
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Sep 26, 2025 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 18, 2025 REPR